1
|
Bebi C, Spinelli MG, Lucignani G, Biondetti P, Martinetti L, Fulgheri I, De Lorenzis E, Albo G, Ierardi A, Palmisano F, Salonia A, Carrafiello G, Montanari E, Boeri L. Spontaneous Upper Urinary Tract Rupture Caused by Ureteric Stones: Clinical Characteristics and Validation of a Radiological Classification System. Diagnostics (Basel) 2021; 11:diagnostics11091568. [PMID: 34573910 PMCID: PMC8471042 DOI: 10.3390/diagnostics11091568] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 08/26/2021] [Accepted: 08/27/2021] [Indexed: 11/16/2022] Open
Abstract
Background: This study seeks to validate a radiological classification system of spontaneous upper urinary tract rupture (sUUTR) and to analyse its relationship with clinical, laboratory and radiological characteristics of sUUTR. Methods: We analysed data from 66 patients with a computerised tomography (CT)-proven sUUTR treated with ureteral or nephrostomy catheter positioning. Comorbidities were scored with the Charlson Comorbidity Index (CCI). All CT scans were reviewed by two experienced radiologists and one urologist, who classified sUUTR in (a) local spread, (b) free fluid and (c) urinoma. Interobserver agreement for radiological score was evaluated with the Intraclass Correlation Coefficient (ICC) and Cohen’s Kappa analyses. Descriptive statistics and logistic regression models verified the association between clinical variables and sUUTR severity. Results: The interobserver agreement for sUUTR classification was high among radiologists and between the radiologists and the urologist (all Kappa > 0.7), with an overall high interrater reliability (ICC 0.82). Local spread, free fluid and urinoma were found in 24 (36.4%), 39 (59.1%) and 3 (4.5%) cases, respectively. Patients with free fluid/urinoma had higher rate of CCI ≥ 1 than those with local spread (40.5% vs. 16.7%, p = 0.04). Intraoperative absence of urine extravasation was more frequently found in patients with local spread than those with free fluid/urinoma (66.7% vs. 28.6%, p < 0.01). Multivariable logistic regression analysis revealed that local spread (OR 4.5, p < 0.01) was associated with absence of contrast medium extravasation during pyelography, after accounting for stone size, fever and CCI. Conclusions: The analysed sUUTR classification score had good inter/intra-reader reliability among radiologists and urologists. Absence of urine extravasation was five times more frequent in patients with local spread, making conservative treatment feasible in these cases.
Collapse
Affiliation(s)
- Carolina Bebi
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
| | - Matteo Giulio Spinelli
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
| | - Gianpaolo Lucignani
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
| | - Pierpaolo Biondetti
- Department of Radiology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (P.B.); (L.M.); (I.F.); (A.I.); (G.C.)
| | - Laura Martinetti
- Department of Radiology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (P.B.); (L.M.); (I.F.); (A.I.); (G.C.)
| | - Irene Fulgheri
- Department of Radiology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (P.B.); (L.M.); (I.F.); (A.I.); (G.C.)
| | - Elisa De Lorenzis
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
- Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy
| | - Giancarlo Albo
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
- Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy
| | - Annamaria Ierardi
- Department of Radiology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (P.B.); (L.M.); (I.F.); (A.I.); (G.C.)
| | - Franco Palmisano
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
| | - Andrea Salonia
- Division of Experimental Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, 20131 Milan, Italy;
| | - Gianpaolo Carrafiello
- Department of Radiology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (P.B.); (L.M.); (I.F.); (A.I.); (G.C.)
| | - Emanuele Montanari
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
- Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy
| | - Luca Boeri
- Department of Urology, Foundation IRCCS Ca’ Granda–Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy; (C.B.); (M.G.S.); (G.L.); (E.D.L.); (G.A.); (F.P.); (E.M.)
- Correspondence: ; Tel.: +39-02-5503-4501
| |
Collapse
|
2
|
Radaelli T, Ferrari MM, Duiella SF, Gazzola FG, Campoleoni M, Merlini C, Martinetti L, Ambrosini MT, Ossola MW, Nicolini A. Prophylactic intraoperative uterine artery embolization for the management of major placenta previa. J Matern Fetal Neonatal Med 2020; 35:3359-3364. [PMID: 32928020 DOI: 10.1080/14767058.2020.1818218] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
PURPOSE Placenta previa is a major cause of maternal morbidity and mortality, associated to a high risk of peripartum hemorrhage and hysterectomy. We aimed to verify if prophylactic intraoperative uterine artery embolization in patients with placenta previa and at least one additional risk of bleeding (major placenta previa), can reduce hemorrhage, need for blood transfusions, peripartum hysterectomy and maternal morbidity. MATERIALS AND METHODS We enrolled 76 patients with major placenta previa; a specific multidisciplinary protocol was designed for management, including ultrasound evaluation, hospitalization at 34 weeks, antenatal corticosteroids and scheduled cesarean section at 35-36 weeks. 44 patients (control group or CTR) were treated with elective cesarean section, 32 patients (embolized group or EMB) underwent selective catheterization of bilateral uterine arteries before cesarean section and subsequent uterine embolization. In both cases cesarean section was performed by a senior surgeon. RESULTS Significant differences were found in term of intraoperative blood loss (CTR: 1431 ml; EMB: 693 ml); despite an high percentage of CTR patients had a bleeding greater than 1000 ml (56%), the need for blood transfusion was not significantly different between the two groups. Time of surgery was higher in the EMB group, considering that embolization procedure required approximatively 30 min. Three patients from the CTR group needed hysterectomy and ICU admission, compared to none in the EMB group. Duration of hospitalization and neonatal outcome were similar. Uterine embolization was not related to any short or long-term complications; return to normal menses and preservation of fertility were confirmed at follow up. CONCLUSIONS Our results are promising, although we believe that a major contribution is referable to the multidisciplinary approach rather than the procedure itself. Nevertheless, we demonstrated the feasibility and safety of preventive uterine embolization in patients with placenta previa; in order to establish its prophylactic role in the prevention of peripartum hemorrhage, randomized trial should be carried out, on a larger population.
Collapse
Affiliation(s)
- Tatjana Radaelli
- Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Maria M Ferrari
- Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Silvia F Duiella
- Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Federica G Gazzola
- Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Mauro Campoleoni
- Department of Medical Physics, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Claudia Merlini
- Department of Anesthesiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Laura Martinetti
- Department of Radiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Maria T Ambrosini
- Department of Anesthesiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Manuela W Ossola
- Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| | - Antonio Nicolini
- Department of Radiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
| |
Collapse
|
3
|
Manini MA, Sangiovanni A, Martinetti L, Viganò D, La Mura V, Aghemo A, Iavarone M, Crespi S, Nicolini A, Colombo M. Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma. Liver Transpl 2015; 21:1259-69. [PMID: 26074360 DOI: 10.1002/lt.24196] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/23/2015] [Revised: 04/30/2015] [Accepted: 05/31/2015] [Indexed: 12/13/2022]
Abstract
Transarterial chemoembolization (TACE) is the standard of care for the treatment of patients with an intermediate (Barcelona Clinic Liver Cancer [BCLC] B) hepatocellular carcinoma and to bridge patients with an early cancer to liver transplantation (LT). We explored the efficacy of TACE with drug-eluting beads (DEB) in BCLC A patients. Included are all BCLC A patients unsuitable for resection or locoregional ablation who underwent a DEB TACE between 2006 and 2012. Treatment was carried out "a la demande" until complete tumor devascularization or progression beyond Milan criteria. In patients with a complete response (CR), a contrast computed tomography (CT) scan was repeated at 3-month intervals during the first 2 years and then every 6 months alternating with abdominal ultrasound in the subsequent 3 years. Fifty-five patients had 79 tumor nodules ranging 7 to 50 mm; 32 (58%) achieved a CR that was maintained up to 4 and 7 months in 21 (38%) and 17 (31%) patients, respectively. The 24- and 36-month tumor-free survivals were 21% and 9%, respectively. The overall cumulative progression beyond Milan criteria at 3, 6, 12, and 24 months was 2%, 5%, 30%, and 54%. LT eligibility was maintained for a median of 19 months (range, 2-63 months). CR to first TACE was the strongest independent predictor of Milan-in maintenance. In conclusion, DEB TACE may effectively bridge patients with an early cancer to LT, and a CR to the first procedure may guide patient prioritization during the waiting list.
Collapse
Affiliation(s)
| | - Angelo Sangiovanni
- Divisions of Gastroenterology and Hepatology, University of Milan, Milan, Italy
| | - Laura Martinetti
- Radiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
| | - Davide Viganò
- Divisions of Gastroenterology and Hepatology, University of Milan, Milan, Italy
| | - Vincenzo La Mura
- Divisions of Gastroenterology and Hepatology, University of Milan, Milan, Italy
| | - Alessio Aghemo
- Divisions of Gastroenterology and Hepatology, University of Milan, Milan, Italy
| | - Massimo Iavarone
- Divisions of Gastroenterology and Hepatology, University of Milan, Milan, Italy
| | - Silvia Crespi
- Radiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
| | - Antonio Nicolini
- Radiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
| | - Massimo Colombo
- Divisions of Gastroenterology and Hepatology, University of Milan, Milan, Italy
| |
Collapse
|
4
|
Abstract
INTRODUCTION The number of patients suffering from primary and secondary liver tumoral diseases is on the increase worldwide. The development of new technologies and drugs requires an increasingly multidisciplinary approach in the management of these diseases. Therapies should be based on scientifically supported guidelines and at the same time should be designed to suit the individual patient. In this decision-making process, an understanding of the advantages and disadvantages of every treatment is very important. The efficacy of transarterial chemoembolization (TACE) in improving survival and its role in the management of hepatocellular carcinoma (HCC) have been demonstrated in several clinical trials. The introduction of drug-eluting beads seems to have overcome some of the limitations of conventional TACE. AREAS COVERED This review provides an overview of the spread of primary and secondary liver cancers, then it explains the basis for the use of conventional TACE and its potential benefits and, finally, outlines its clinical application and possible future uses. EXPERT OPINION The management of the treatment of focal liver lesions is a difficult process, which must involve various specialists such as the interventional radiologist. The use of drug-eluting microspheres seems to improve the results of TACE both in HCC and in colorectal liver metastases.
Collapse
Affiliation(s)
- Antonio Nicolini
- IRCCS-Fondazione Ca' Granda Ospedale Maggiore Policlinico Milano, Interventional radiology, Via Francesco Sforza 35, Milano 20100, Italy.
| | | | | |
Collapse
|
5
|
Nicolini A, Sangiovanni A, Iavarone M, Martinetti L, Manini MA, Crespi S, Della Corte C, Vavassori S, Colombo M. Chemoembolization with epirubicin drug-eluting beads (DEB-TACE) to treat early and intermediate hepatocellular carcinoma. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6
|
Nicolini A, Martinetti L, Crespi S, Maggioni M, Sangiovanni A. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol 2010; 21:327-32. [PMID: 20097098 DOI: 10.1016/j.jvir.2009.10.038] [Citation(s) in RCA: 109] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2008] [Revised: 10/05/2009] [Accepted: 10/12/2009] [Indexed: 02/07/2023] Open
Abstract
PURPOSE To retrospectively compare radiologic tumor response and degree of necrosis in explanted livers after chemoembolization with epirubicin-loaded DC Bead versus bland embolization in patients on a transplant waiting list. MATERIALS AND METHODS From 2003 to 2007, 49 patients with hepatocellular carcinoma (HCC) underwent transplantation at a single center. Sixteen patients were treated with bland embolization (n = 8) with 100-300-microm Embosphere particles or chemoembolization with epirubicin-loaded 100-300-microm DC Bead particles (n = 8) every other month until complete tumor devascularization. Computed tomography was performed every 3 months until recurrence. Explanted livers were analyzed to evaluate the degree of necrosis in the nodules. After orthotopic liver transplantation (OLT), patients were followed up for survival and disease status. RESULTS The groups were comparable for baseline characteristics. Most patients had Child-Pugh class A disease. Solitary HCC was found in 75% of patients. Mean target lesion size was 32 mm +/- 15.4. Chemoembolization with drug-eluting beads achieved complete necrosis in 77% of lesions whereas bland embolization achieved complete necrosis in 27.2% of lesions. There was a significant difference between bland embolization and chemoembolization with DC Bead with regard to histologic necrosis (P = .043). No significant treatment-related complications were observed for either group. Fifteen patients are alive with no tumor recurrence. CONCLUSIONS Chemoembolization with drug-eluting beads before OLT achieved higher rates of complete histologic response than bland embolization, with no serious adverse events observed. Because of the retrospective data analyses and small sample size, further studies are warranted to confirm these promising results.
Collapse
Affiliation(s)
- Antonio Nicolini
- Division of Radiology, Operative Unit for Interventional Radiology, Istituto Di Ricovero e Cura a Carattere Scientifico-Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, University of Milan, Via Francesco Sforza 35, Milan MI20100, Italy.
| | | | | | | | | |
Collapse
|
7
|
Alberici A, Quattrini E, Penati M, Martinetti L, Marino Gallina P, Ferrante A, Schiavi M. EFFECT OF THE REDUCTION OF NUTRIENT SOLUTION CONCENTRATION ON LEAFY VEGETABLES QUALITY GROWN IN FLOATING SYSTEM. ACTA ACUST UNITED AC 2008. [DOI: 10.17660/actahortic.2008.801.142] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
8
|
Nicolini A, Martinetti L, Crespi S, Forzenigo L, Rossi G, Colombo M. Abstract No. 349: Treatment of HCC with Drug Eluting Beads Versus Microspheres before Transplant: Imaging and Hystology Results. J Vasc Interv Radiol 2008. [DOI: 10.1016/j.jvir.2007.12.402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
9
|
Scarponi L, Buonaurio R, Martinetti L. Persistence and translocation of a benzothiadiazole derivative in tomato plants in relation to systemic acquired resistance against Pseudomonas syringae pv tomato. Pest Manag Sci 2001; 57:262-268. [PMID: 11455656 DOI: 10.1002/ps.285] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
A reproducible and accurate procedure, based on HPLC analysis, has been developed to determine simultaneously acibenzolar-S-methyl (CGA 245 704) and its acid derivative (CGA 210 007) in tomato leaves. The limit of detection and quantification of the method are 0.015 and 0.15 mg litre-1 for CGA 245 704 and 0.030 and 0.30 mg litre-1 for CGA 210 007. In tomato plants treated with 250 microM CGA 245 704, it was found that the inducer rapidly translocates from treated leaves (cotyledons, 1st and 2nd) to untreated leaves (3rd to 5th), with the maximum translocation (40% of the total quantity found) occurring 8 h after the treatment. CGA 245 704 residues decreased as time elapsed in both treated and untreated tomato leaves, reaching negligible values 72 h after treatment. The acid derivative, CGA 210 007, was formed in tomato plants as early as 2 h after CGA 245 704 treatment, albeit only in the treated leaves. CGA 210 007 residues decreased in treated tomato leaves with a trend similar to that observed for CGA 245 704. Treatment of tomato plants with CGA 245 704 or CGA 210 007 at 250 microM systemically protected the plants against Pseudomonas syringae pv tomato attacks, the causal agent of bacterial speak disease. Evidence of this were reductions in the degree of infection, the bacterial lesion diameter and the bacterial growth in planta. Since neither CGA 245 704 nor CGA 210 007 inhibited bacterial growth in vitro and the protection against bacterial speak of tomato was observed when the two compounds were completely degraded, the protection must be due to the activation of the plant's defence mechanisms.
Collapse
Affiliation(s)
- L Scarponi
- Centro di Studio sulla Chimica e Biochimica del Fitofarmaci del CNR, Borgo XX Giugno, 72-06121 Perugia, Italy.
| | | | | |
Collapse
|
10
|
Bonati P, Martinetti L, Musante F, Rosti G. [Case of Caroli's disease diagnosed with a non-invasive method]. Radiol Med 1981; 67:662-4. [PMID: 7313182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
11
|
Martinetti L, Monafo V. A clinical study of diviminol on prolonged administration. Int Z Klin Pharmakol Ther Toxikol 1971; 4:298-302. [PMID: 4931415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
12
|
Martinetti L, Lodola E, Monafo V, Ferrari V. Clinical evaluation of an oral analgesic, Z.424, in patients with chronic pain. J Clin Pharmacol J New Drugs 1970; 10:390-9. [PMID: 4920491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
13
|
Martinetti L, Lai G. [On several anti-hypertensive drugs with special reference to the association of dihydroergocristine, reserpine and clopamide]. Arch Maragliano Patol Clin 1970; 26:209-18. [PMID: 5002193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
14
|
Martinetti L, Lai G, Rovera R. [Clinical observations on the use of a combination of proscillaridin and theophylline in the treatment of the senile heart and chronic cor pulmonale]. Clin Ter 1968; 46:517-42. [PMID: 5754593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
15
|
Martinetti L, Furlotti-Marino G. [Clinical observations on the treatment of myocardial infarct with dipyridamole and polarizing solutions in intravenous administration]. Minerva Med 1968; 59:3522-45. [PMID: 5676220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
16
|
Martinetti L, Balzano I. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion]. Minerva Med 1966; 57:2699-710. [PMID: 5911867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
17
|
Martinetti L, Lai G, Ceriolo L, Barberis S. [Controlled study of the pharmacologic effects on gastric emptying]. Clin Ter 1966; 37:342-9. [PMID: 5924248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
18
|
Martinetti L, Lai G. [Clinical observations on the use of a new cardioactive glycoside: proscillaridin A]. Minerva Med 1966; 57:1994-9. [PMID: 5943258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|